Commonwealth Equity Services LLC Sells 800 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

Commonwealth Equity Services LLC trimmed its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 1.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 72,123 shares of the company’s stock after selling 800 shares during the quarter. Commonwealth Equity Services LLC’s holdings in OrthoPediatrics were worth $1,672,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Wellington Management Group LLP increased its holdings in shares of OrthoPediatrics by 16.2% during the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock worth $23,944,000 after buying an additional 122,846 shares in the last quarter. Portolan Capital Management LLC grew its position in OrthoPediatrics by 66.2% during the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock worth $8,353,000 after acquiring an additional 122,770 shares during the last quarter. Polar Asset Management Partners Inc. bought a new stake in OrthoPediatrics during the 3rd quarter worth $2,288,000. Mutual of America Capital Management LLC increased its holdings in OrthoPediatrics by 57.1% in the 4th quarter. Mutual of America Capital Management LLC now owns 169,021 shares of the company’s stock worth $3,918,000 after purchasing an additional 61,412 shares in the last quarter. Finally, Barclays PLC raised its position in OrthoPediatrics by 319.3% in the third quarter. Barclays PLC now owns 25,298 shares of the company’s stock valued at $686,000 after purchasing an additional 19,264 shares during the last quarter. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Price Performance

Shares of KIDS opened at $24.74 on Friday. The business has a 50-day moving average of $24.75 and a 200-day moving average of $25.28. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The company has a market capitalization of $600.86 million, a price-to-earnings ratio of -20.11 and a beta of 1.22. OrthoPediatrics Corp. has a 1 year low of $21.02 and a 1 year high of $35.99.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The firm had revenue of $52.67 million during the quarter, compared to analyst estimates of $51.16 million. During the same quarter last year, the business earned ($0.23) EPS. As a group, equities research analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on KIDS shares. Stifel Nicolaus lowered their price objective on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a research note on Wednesday, March 5th. Truist Financial reduced their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a report on Wednesday, December 18th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Wednesday, March 5th.

Insider Buying and Selling

In related news, insider Gregory A. Odle sold 5,359 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the transaction, the insider now directly owns 148,788 shares of the company’s stock, valued at approximately $3,698,869.68. This represents a 3.48 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David R. Bailey sold 6,620 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $164,573.20. Following the completion of the transaction, the chief executive officer now owns 319,155 shares in the company, valued at approximately $7,934,193.30. This represents a 2.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 23,732 shares of company stock valued at $589,978 over the last quarter. Insiders own 31.80% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.